Skip to main content
UniHealth

Doctor search

Pradipta Ghosh, MD

Rheumatology · Loma Linda

NPI 1538219936

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
Not verified
Not the same as out of network.
Offices
2

Offices

2 locations · Faculty Physicians and Surgeons of Llusm · County of Riverside

Looking this up.

Hospitals listed: Loma Linda University Medical Center · Riverside University Health System-Medical Center. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Ghosh’s office at (909) 558-2154 to ask if they take your plan before you enroll.

California Medical Board record

Licence A96208 · Current

Licensed to practise in California · since 2006 · expires 2028-02-29 · Marshall University School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

State licence records

1 licence

  • Washington MD.MD.60088193Physician And Surgeon License · since 2009 · expires 2012-02-24
    ExpiredNo board action on this licenceCheck it with the state

We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Loma Linda University Medical CenterLoma Linda, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Loma Linda University Health, which runs 4 hospitalsPatients rate it 3 of 5 · 78% would definitely recommend it
    Overall rating: 4 of 5 starsBetter than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 0.71 (0.47 to 0.96), Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.146, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.468, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.383, Oct 2024 – Sep 2025
  • Riverside University Health System-Medical CenterMoreno Valley, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Riverside University Health SystemPatients rate it 2 of 5 · 66% would definitely recommend it
    Overall rating: 3 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.232, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.157, Oct 2024 – Sep 2025
See every measure and the patient survey for Loma Linda University Medical Center

Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 5 better, 2 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Loma Linda University Medical Center
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.71 (0.47 to 0.96)BetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.146BetterOct 2024 – Sep 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.468BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.383BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.66 (0 to 1.53) · 2,053 casesNo differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths173.35 (135.58 to 211.11) · 169 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.3 · 54 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 79 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths11.9 · 100 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9.1 · 285 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths14.6 · 272 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths11 · 421 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3.7 · 3,758 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.28 (0.09 to 0.47) · 7,732 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.33 (0.15 to 0.52) · 8,479 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths2.88 (1.14 to 4.63) · 2,571 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.04 (0 to 2.41) · 933 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.85 (1.66 to 4.04) · 2,380 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths5.16 (0.2 to 10.13) · 908 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths3.42 (0.42 to 6.42) · 988 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths2.29 (0.91 to 3.67) · 677 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.37 (0 to 0.85) · 7,115 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.2 · 37 casesNoneApr 2023 – Mar 2025
MRSA BacteremiaInfections0.685No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.751No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.702No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits15.4 · 380 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits21 · 660 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits15.1 · 167 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits29.6 · 365 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-17.5 · 282 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits18.6 · 513 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.4 (4 to 7.3) · 422 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits12.6 (10.2 to 15.5) · 422 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.8 · 36 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.4 · 89 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits21.5 · 190 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits13.6 (10.4 to 18.1) · 720 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.9 (0.7 to 1.2) · 778 casesNo differentJan 2024 – Dec 2024

What patients said (3,684 patients answered, 19% of those asked)

Patient survey stars by topic at Loma Linda University Medical Center
Cleanliness4
Nurse communication3
Doctor communication3
Communication about medicines3
Discharge information3
Overall hospital rating4
Quietness3
Recommend hospital5
Share of patients giving the best answer at Loma Linda University Medical Center
Room was "always" clean73%
Nurses "always" communicated well75%
Doctors "always" communicated well77%
Staff "always" explained57%
Yes, staff "did" give patients this information86%
Yes, staff "did" give patients information about help after discharge85%
Doctors "always" explained things so they could understand72%
Doctors "always" listened carefully75%
Doctors "always" treated them with courtesy and respect83%
Patients who gave a rating of "9" or "10" (high)74%
Staff "always" explained new medications71%
Nurses "always" explained things so they could understand71%
Nurses "always" listened carefully73%
Nurses "always" treated them with courtesy and respect83%
"Always" quiet at night52%
"YES", patients would definitely recommend the hospital78%
Staff "always" explained possible side effects43%
Yes, staff "did" give patients information about possible symptoms86%
See every measure and the patient survey for Riverside University Health System-Medical Center

Behind the star rating — Deaths: 0 better, 6 the same, 0 worse of 6 measures. Safety: 4 better, 3 the same, 0 worse of 7 measures. Readmissions: 0 better, 7 the same, 1 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Riverside University Health System-Medical Center
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.232BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.157BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.38 (0.38 to 2.38) · 932 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.93 (0.56 to 1.3)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths191.06 (136.87 to 245.25) · 59 casesNo differentJul 2022 – Jun 2024
Death rate for COPD patientsComplications and deaths9.1 · 77 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths11.5 · 25 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths7.7 · 140 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths13.7 · 148 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths11.1 · 184 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3.1 · 2,070 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.24 (0.02 to 0.46) · 4,158 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.35 (0.15 to 0.55) · 4,169 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.45 (1.15 to 5.76) · 582 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.6 (0 to 3.29) · 126 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths1.98 (0.38 to 3.58) · 580 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths9.8 (0.71 to 18.89) · 135 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths4.67 (0.57 to 8.78) · 125 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.67 (0.18 to 3.16) · 159 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.38 (0 to 1.09) · 3,702 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4.1 · 48 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.517No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections1.484No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.896No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.404No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits15 · 46 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits22.1 · 303 casesNoneJul 2023 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits7.1 · 162 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits1 · 164 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits19 · 290 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits6 (3.8 to 9.1) · 36 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits11.9 (8.1 to 16.7) · 36 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.8 · 60 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits20.2 · 151 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.6 (9.3 to 17) · 127 casesNo differentJan 2022 – Dec 2024

What patients said (416 patients answered, 10% of those asked)

Patient survey stars by topic at Riverside University Health System-Medical Center
Cleanliness2
Nurse communication2
Doctor communication2
Communication about medicines2
Discharge information3
Overall hospital rating3
Quietness2
Recommend hospital3
Share of patients giving the best answer at Riverside University Health System-Medical Center
Room was "always" clean63%
Nurses "always" communicated well73%
Doctors "always" communicated well74%
Staff "always" explained54%
Yes, staff "did" give patients this information85%
Yes, staff "did" give patients information about help after discharge86%
Doctors "always" explained things so they could understand69%
Doctors "always" listened carefully72%
Doctors "always" treated them with courtesy and respect82%
Patients who gave a rating of "9" or "10" (high)65%
Staff "always" explained new medications72%
Nurses "always" explained things so they could understand69%
Nurses "always" listened carefully69%
Nurses "always" treated them with courtesy and respect81%
"Always" quiet at night46%
"YES", patients would definitely recommend the hospital66%
Staff "always" explained possible side effects37%
Yes, staff "did" give patients information about possible symptoms84%

Original Medicare doctor bills

$6,363

Medicare paid this office $6,363 for 57 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes21$2,186$104
Return visit (30+ min)14$1,396$100

Who their Medicare patients are

57 Original Medicare patients in 2024. Average age 72 · Women 74% · Also on Medicaid 65% · Health risk score 2.62. Sicker patients than 9 in 10 peers; the typical rheumatology clinician is at 1.38.

Conditions among them: High blood pressure 75% · Diabetes 47% · Chronic kidney disease 42% · Heart failure 40% · COPD 32% · Atrial fibrillation 32% · Coronary heart disease 28% · Dementia 28% · Depression 26% · Cancer 25% · Stroke 23%.

The office billed $24,285, Medicare allowed $8,154 and paid $6,363; for 68 services of 12 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Medicaid work

$87,463 in 2024

Medicaid paid $87,463 for 1,080 billed services this clinician did in 2024, up to 46 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
Clinic visit/encounter, all-inclusive287$77,409
Return visit (30+ min)486$9,192
Screening for depression is documented as negative, a follow-up plan is not required143$862
Alcohol and/or drug screening164$0
Medicaid work by year
20241,080446$87,463

Drugs they prescribed that Part D paid

$323,523

Pharmacies billed $323,523 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 248) in 2024. At or below the middle of the specialty; the typical rheumatology clinician is at 3%.

211 generic and fewer than 11 brand-name prescriptions · $323,523 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Humira(Cf)15$139,916$9,328
Hydroxychloroquine Sulfate40$1,078$27
Mycophenolate Mofetil17$745$44
Methotrexate31$712$23
Gabapentin18$578$32
See all 8 drugs
Every Part D drug this clinician prescribed
Humira(Cf)15$139,916$9,328
Hydroxychloroquine Sulfate40$1,078$27
Mycophenolate Mofetil17$745$44
Methotrexate31$712$23
Gabapentin18$578$32
Leflunomide12$371$31
Prednisone13$102$8
Allopurinol12$54$5

Year by year

Part D prescribing by year
2024248840% (0)None$323,523
20236463050% (0)None$475,540
20221,2593291% (11)None$886,841
20211,032247NoneNone$781,197
20201,002236NoneNone$662,070
2019871241NoneNone$513,693
2018992258NoneNone$489,486
2017929255NoneNone$367,173
2016822225NoneNone$297,613
20157212353% (20)None$224,225
20146492164% (23)33%$225,420
20135211992% (12)37%$104,840

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 16 drugs

Part D drugs prescribed in 2023
Enbrel Sureclick17$89,046$5,238
Orencia14$62,637$4,474
Enbrel14$58,025$4,145
Xeljanz13$44,023$3,386
Actemra Actpen16$30,124$1,883
Amjevita(Cf)13$23,645$1,819
Rasuvo21$18,090$861
Methotrexate147$2,598$18
Hydroxychloroquine Sulfate78$2,496$32
Mycophenolate Mofetil23$2,478$108
Leflunomide38$1,437$38
Prednisone85$1,200$14
Diclofenac13$420$32
Allopurinol18$192$11
Alendronate16$166$10
Meloxicam11$114$10

2022: 25 drugs

Part D drugs prescribed in 2022
Enbrel Sureclick30$153,946$5,132
Enbrel34$148,905$4,380
Orencia30$126,187$4,206
Humira24$116,083$4,837
Xeljanz31$71,579$2,309
Humira12$57,782$4,815
Actemra Actpen20$57,287$2,864
Rasuvo51$57,209$1,122
Humira(Cf)11$49,114$4,465
Methotrexate292$6,051$21
Mycophenolate Mofetil42$4,980$119
Hydroxychloroquine Sulfate86$4,547$53
Leflunomide98$4,325$44
Prednisone207$2,683$13
Sulfasalazine19$772$41
Diclofenac19$576$30
Allopurinol37$537$15
Gabapentin24$476$20
Colchicine13$409$31
Leucovorin15$355$24
Duloxetine15$260$17
Meloxicam20$199$10
Celecoxib12$194$16
Omeprazole13$140$11
Alendronate11$112$10

2021: 20 drugs

Part D drugs prescribed in 2021
Enbrel63$287,840$4,569
Xeljanz29$79,653$2,747
Enbrel Sureclick16$78,840$4,927
Humira15$63,524$4,235
Humira14$61,418$4,387
Humira(Cf)12$50,683$4,224
Rasuvo38$46,301$1,218
Methotrexate265$6,256$24
Leflunomide89$5,115$57
Hydroxychloroquine Sulfate71$3,598$51
Mycophenolate Mofetil26$3,545$136
Prednisone150$3,531$24
Sulfasalazine25$752$30
Pilocarpine17$641$38
Diclofenac22$528$24
Leucovorin20$516$26
Allopurinol30$448$15
Gabapentin19$390$21
Meloxicam16$161$10
Alendronate14$146$10

2020: 15 drugs

Part D drugs prescribed in 2020
Enbrel55$241,658$4,394
Xeljanz Xr22$87,527$3,978
Xeljanz36$84,357$2,343
Humira17$64,204$3,777
Rasuvo38$53,909$1,419
Orencia11$42,734$3,885
Methotrexate284$6,792$24
Leflunomide105$6,510$62
Mycophenolate Mofetil25$3,927$157
Prednisone168$3,852$23
Hydroxychloroquine Sulfate64$3,061$48
Sulfasalazine24$1,271$53
Diclofenac28$1,039$37
Leucovorin14$389$28
Allopurinol12$225$19

2019: 15 drugs

Part D drugs prescribed in 2019
Enbrel51$218,459$4,284
Xeljanz Xr18$65,858$3,659
Orencia14$51,350$3,668
Rasuvo39$48,412$1,241
Xeljanz21$47,025$2,239
Humira11$44,724$4,066
Leflunomide78$8,410$108
Methotrexate255$6,235$24
Mycophenolate Mofetil21$4,319$206
Prednisone166$3,767$23
Hydroxychloroquine Sulfate39$3,605$92
Diclofenac25$1,411$56
Sulfasalazine17$987$58
Gabapentin11$622$57
Meloxicam14$112$8

2018: 16 drugs

Part D drugs prescribed in 2018
Enbrel50$216,642$4,333
Xeljanz28$81,539$2,912
Rasuvo47$50,815$1,081
Xeljanz Xr11$37,153$3,378
Leflunomide67$23,847$356
Methotrexate277$16,642$60
Colchicine12$5,364$447
Prednisone194$5,050$26
Hydroxychloroquine Sulfate88$4,186$48
Diclofenac30$1,583$53
Gabapentin24$1,139$47
Sulfasalazine17$1,137$67
Duloxetine24$761$32
Allopurinol12$302$25
Alendronate16$203$13
Meloxicam16$142$9

2017: 15 drugs

Part D drugs prescribed in 2017
Enbrel41$161,375$3,936
Enbrel Sureclick11$42,810$3,892
Xeljanz12$37,635$3,136
Rasuvo25$31,386$1,255
Leflunomide70$25,889$370
Methotrexate295$15,821$54
Colchicine16$5,368$336
Hydroxychloroquine Sulfate54$4,781$89
Prednisone191$4,603$24
Diclofenac23$1,295$56
Sulfasalazine13$1,231$95
Allopurinol18$625$35
Gabapentin11$450$41
Meloxicam28$281$10
Alendronate17$242$14

2016: 10 drugs

Part D drugs prescribed in 2016
Enbrel49$178,487$3,643
Leflunomide69$20,447$296
Methotrexate262$15,134$58
Hydroxychloroquine Sulfate53$12,539$237
Colchicine27$9,935$368
Prednisone171$4,785$28
Sulfasalazine15$2,152$143
Allopurinol21$1,001$48
Meloxicam34$394$12
Alendronate18$262$15

2015: 11 drugs

Part D drugs prescribed in 2015
Enbrel33$89,295$2,706
Humira25$66,706$2,668
Methotrexate196$7,830$40
Prednisone185$5,723$31
Colchicine20$5,556$278
Leflunomide59$5,328$90
Hydroxychloroquine Sulfate33$4,799$145
Voltaren16$1,049$66
Allopurinol17$1,040$61
Hydrocodone-Acetaminophen11$398$36
Alendronate11$164$15

2014: 11 drugs

Part D drugs prescribed in 2014
Enbrel45$101,254$2,250
Humira30$66,794$2,226
Methotrexate183$15,674$86
Colcrys25$12,194$488
Leflunomide53$5,562$105
Prednisone137$4,180$31
Sulfazine11$1,221$111
Allopurinol30$1,036$35
Hydroxychloroquine Sulfate23$928$40
Voltaren15$906$60
Hydrocodone-Acetaminophen14$272$19

2013: 8 drugs

Part D drugs prescribed in 2013
Enbrel25$52,271$2,091
Colcrys34$16,946$498
Methotrexate102$7,827$77
Prednisone152$3,448$23
Leflunomide33$3,357$102
Hydroxychloroquine Sulfate22$928$42
Sulfazine12$880$73
Allopurinol28$828$30

Money from drug and device companies

$119 in 2024

A payment is not proof that care is biased.

Payments by company
Aurinia Pharma U.S.Lupkynis$119
1 payment
  • Meals for Lupkynis · 2024-12-12 · $119
See the published payment
Every published payment
Aurinia Pharma U.S.Meals · 2024-12-12Lupkynis$119

Professional record

NPI
1538219936
Licence
CA A96208, WA MD60088193California A96208: Current · expires 2028-02-29Washington MD.MD.60088193: Expired
Trained
Jc Edwards School of Medicine, Marshall University, 2004
Group
Faculty Physicians and Surgeons of Llusm · County of Riverside
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 207RR0500X (207RR0500X); Internal medicine (207R00000X)
Mailing address
710 Lawrence Expy, Department 272, Rheumatology, Santa Clara, CA, 95051
NPI first listed
2007-01-10
NPI last updated
2021-12-14

This is when the NPI record was last certified, not a medical board exam.

This office lists an electronic records connection.